Nicolas Leupin

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Baar
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
Steven Robbins, as attorney in fact for Leupin, Nicolas
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Nicolas Leupin

Form 4 holding Former Chief Medical Officer

NovoCure Ltd

Security class
Stock Options (Right to buy)
Shares / value
81,499
Estimated value
$1,482,467
Report date
04 Mar 2025
Price
$18.19
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Former Chief Medical Officer

NovoCure Ltd

Security class
Ordinary Shares
Shares / value
102,979
Estimated value
$1,370,176
Report date
04 Mar 2026
Price
$13.31
Ownership
Direct

Insider Reports Filed by Nicolas Leupin

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .